$86.9 Billion is the total value of Mayo Clinic's 8 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BSM | BLACK STONE MINERALSbsm | $49,877,737,000 | +130439.2% | 5,719,924 | 0.0% | 57.42% | +24.9% | |
ZNTL | Zentalis Pharmaceuticals Inczntl | $15,727,096,000 | +83439.2% | 362,459 | 0.0% | 18.11% | -20.1% | |
UBX | UNITY BIOTECHNOLOGY INCubx | $9,431,886,000 | +114406.3% | 1,571,981 | 0.0% | 10.86% | +9.6% | |
BSGM | BIOSIG TECH INCbsgm | $434,840,000 | +110546.3% | 100,891 | 0.0% | 0.50% | +5.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BLACK STONE MINERALS | 11 | Q3 2023 | 82.2% |
Evelo Bioseciences Inc | 11 | Q3 2023 | 7.3% |
BIOSIG TECH INC | 10 | Q2 2023 | 6.7% |
Clearpoint Neuro Inc (Frmly MRI INTERVENTIONS INC) | 10 | Q3 2023 | 3.5% |
Zentalis Pharmaceuticals Inc | 9 | Q3 2023 | 22.6% |
UNITY BIOTECHNOLOGY INC | 8 | Q4 2022 | 23.1% |
EXACT SCIENCES CORP | 7 | Q2 2023 | 4.5% |
Neuroon Medical Technologies | 5 | Q3 2023 | 1.3% |
MSCI ACWI ETF | 4 | Q3 2023 | 89.6% |
Sorrento Therapeutics | 4 | Q4 2022 | 6.1% |
View Mayo Clinic's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
VENTURE LENDING & LEASING IV INC | March 16, 2005 | 6,000 | 6.0% |
View Mayo Clinic's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-13 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-05 |
13F-HR/A | 2023-02-09 |
13F-HR | 2023-01-26 |
13F-HR | 2021-08-12 |
13F-HR | 2021-05-13 |
13F-HR | 2021-02-11 |
View Mayo Clinic's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.